Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Tilg

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
International Journal of Sports Medicine|December 2, 2005
The impact of prolonged strenuous endurance exercise on interleukin 18 and interleukin 18 binding protein in recreational cyclistsG Neumayr, O Ludwiczek, H Hoertnagl, et al.
Clinical and Experimental Immunology|November 1, 1991
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma)W E Aulitzky, H Grosse-Wilde, U Westhoff, et al.
Transplantation|July 1, 1992
Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantationH Tilg, J Nordberg, W Vogel, et al.
Gut|March 9, 2005
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone lossA R Moschen, A Kaser, B Enrich, et al.
Transplantation|October 1, 1990
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messagesD Niederwieser, M Herold, W Woloszczuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Biologic activity of low dosage IL-2 treatment in vivo. Molecular assessment of cytokine network interactionF Hladik, J A Tratkiewicz, H Tilg, et al.
Klinische Wochenschrift|December 11, 1991
Plasma levels of atrial natriuretic peptide and tumor necrosis factor-alpha during transient myocardial ischemia in patients with stable anginaC J Wiedermann, F J Wiedermann, M Herold, et al.
Acta Medica Austriaca|January 1, 1985
[Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon]W Aulitzky, G Gastl, J Troppmair, et al.
Immunobiology|June 1, 1990
Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alphaW E Aulitzky, W K Aulitzky, J Frick, et al.
Immunopharmacology|February 9, 1999
Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophilsP Schratzberger, S Dunzendorfer, N Reinisch, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
International Journal of Sports Medicine|December 2, 2005
The impact of prolonged strenuous endurance exercise on interleukin 18 and interleukin 18 binding protein in recreational cyclistsG Neumayr, O Ludwiczek, H Hoertnagl, et al.
Clinical and Experimental Immunology|November 1, 1991
Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma)W E Aulitzky, H Grosse-Wilde, U Westhoff, et al.
Transplantation|July 1, 1992
Circulating serum levels of interleukin 6 and C-reactive protein after liver transplantationH Tilg, J Nordberg, W Vogel, et al.
Gut|March 9, 2005
The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone lossA R Moschen, A Kaser, B Enrich, et al.
Transplantation|October 1, 1990
Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messagesD Niederwieser, M Herold, W Woloszczuk, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1994
Biologic activity of low dosage IL-2 treatment in vivo. Molecular assessment of cytokine network interactionF Hladik, J A Tratkiewicz, H Tilg, et al.
Klinische Wochenschrift|December 11, 1991
Plasma levels of atrial natriuretic peptide and tumor necrosis factor-alpha during transient myocardial ischemia in patients with stable anginaC J Wiedermann, F J Wiedermann, M Herold, et al.
Acta Medica Austriaca|January 1, 1985
[Results of a phase II study on the treatment of hairy cell leukemias with various doses of alpha-2-recombinant interferon]W Aulitzky, G Gastl, J Troppmair, et al.
Immunobiology|June 1, 1990
Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alphaW E Aulitzky, W K Aulitzky, J Frick, et al.
Immunopharmacology|February 9, 1999
Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophilsP Schratzberger, S Dunzendorfer, N Reinisch, et al.
Pageof 15